How obesity reshapes pancreatic immunity

The pancreas does more than produce insulin. Most of the organ makes digestive enzymes, and this exocrine compartment is where obesity reshapes pancreatic immunity most visibly. Immune cells become denser, more cytotoxic, and arranged into small inflammatory neighborhoods that may help sustain local tissue stress.

The researchers studied pancreatic tissue from 68 deceased adult organ donors without cancer, chronic pancreatitis, or known autoimmune disease. They combined highly multiplexed imaging, flow cytometry, bulk and single-cell gene-expression analysis, and experiments in which immune cells were cultured together. This allowed them to examine not only which cells were present, but where they were positioned and how they could influence one another.

Immune cells gather in specific pancreatic regions

Spatial imaging was performed on tissue from 32 donors aged 18 to 71. Body mass index ranged from 21 to 47 kg/m², and 20 donors met the BMI definition of obesity. Higher BMI was associated with greater T-cell density in the exocrine pancreas, particularly around the acinar and ductal structures involved in producing and transporting digestive enzymes. Within the hormone-producing islets, the strongest BMI-associated increase involved macrophages.

The team focused on tissue-resident memory T cells. Unlike immune cells that continually circulate through the bloodstream, these cells remain within a particular organ and are prepared to respond rapidly to local danger signals. Their proportion among pancreatic T cells did not substantially change with BMI, but the overall density of T cells increased. The tissue therefore contained more of the same dominant resident population rather than a completely different mixture of T-cell types.

Imaging also revealed a spatial reorganization. In donors with higher BMI, T cells were more likely to form large clusters around macrophages expressing high levels of CD11c, especially near pancreatic ducts. The significance is not merely that both cell types were present: they were positioned closely enough to repeatedly stimulate one another.

Two macrophage programs with different functions

Single-cell sequencing identified two major macrophage states. One was associated with tissue repair and immune regulation. The other was adapted to lipid handling, interacted more strongly with T cells, and carried a more inflammatory program. Obesity shifted the balance toward this second, lipid-associated macrophage population.

Tissue-resident T cells also showed obesity-related changes. In a smaller analysis of 11 donors, pancreatic T cells differed at 738 genes between donors with and without obesity. Many of the increased programs involved interferon responses and cytotoxicity, the machinery immune cells use to damage target cells. By comparison, only five obesity-associated gene differences were found in T cells from lymphoid tissues, suggesting that the response was strongly shaped by the pancreatic environment.

Co-culture experiments provided a possible mechanism. Pancreatic macrophages supplied several signals to T cells: TGF-β promoted features that help T cells remain in tissue, while CD58 and CD86 strengthened effector functions. Blocking these signals reduced the appearance of molecules linked to tissue residency and cytotoxicity. The inflammatory macrophage subset drove stronger T-cell effector responses than the more regulatory subset.

This does not establish macrophages as the single cause of pancreatic inflammation. The experiments were performed outside the body and reproduce only part of a complex tissue environment. Combined with the spatial observations, however, they support a plausible circuit: excess nutrients and lipids alter macrophage states, those macrophages interact more intensely with resident T cells, and the resulting cellular network helps maintain inflammation around the exocrine epithelium.

What the study explains—and what it cannot yet prove

Obesity is associated with higher risks of diabetes, pancreatitis, and pancreatic cancer. This study offers a possible intermediate step between systemic metabolic stress and local pancreatic injury. The immune landscape does not simply become more inflamed in a diffuse way; it is reorganized into persistent cellular neighborhoods with defined macrophage–T-cell interactions.

The study was cross-sectional, meaning that each donor’s tissue was examined at one point in time. It therefore cannot determine whether the immune changes preceded inflammation or developed as a consequence of it. Statistical models accounted for age, sex, and diabetes, but unknown confounders may remain. BMI is also an imperfect measure: it does not distinguish fat from lean mass and does not capture the distribution of fat, including visceral adiposity around internal organs.

The researchers did not follow donors for the development of diabetes, pancreatitis, or cancer, and they did not test whether weight loss dismantles these inflammatory networks. The work therefore does not show that the identified immune changes directly cause pancreatic disease. What it provides is a detailed cellular map and a set of testable interactions that future studies can examine.